INO-6001

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameINO-6001
Drug Alias NameINO-6001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase modulators
TargetsSuperoxide dismutase
Therapy Area/IndicationsMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRocket Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A